Asset Management Resources’s Pfizer PFE Stock Holding History

Asset Management Resources’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$238K	Sell	8,281 -7,436	-47%	-$225K	0.14%	49
2023 Q3	$521K	Buy	15,717 +204	+1%	+$7.21K	0.32%	25
2023 Q2	$569K	Buy	15,513 +2,438	+19%	+$94.9K	0.35%	22
2023 Q1	$533K	Buy	13,075 +2,305	+21%	+$99.6K	0.34%	24
2022 Q4	$552K	Buy	10,770 +58	+0.5%	+$2.78K	0.37%	26
2022 Q3	$469K	Buy	10,712 +486	+5%	+$23.6K	0.46%	25
2022 Q2	$536K	Sell	10,226 -800	-7%	-$40.8K	0.46%	21
2022 Q1	$571K	Buy	11,026 +2,326	+27%	+$121K	0.46%	23
2021 Q4	$514K	Buy	+8,700	New	+$431K	0.45%	22

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Asset Management Resources's PFE Position: Q4 2023 in Review

Asset Management Resources reduced its Pfizer (PFE) stake by 47% in Q4 2023, selling an estimated $225K and leaving 8,281 shares worth $238K. The position accounts for 0.14% of the portfolio, ranked #49.

Asset Management Resources first reported a position in PFE in Q4 2021 and has held it in 9 quarters since. The position peaked at $571K in Q1 2022. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Asset Management Resources held 8,281 shares of Pfizer worth $238K as of Q4 2023.
Asset Management Resources sold 7,436 Pfizer shares in Q4 2023, an estimated $225K.
Pfizer made up 0.14% of Asset Management Resources's portfolio in Q4 2023, its #49 holding.
Asset Management Resources first reported a position in Pfizer in Q4 2021 and has held it in 9 quarters since.
Asset Management Resources's Pfizer position peaked at $571K in Q1 2022.
2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Asset Management Resources's 13F filing for Q4 2023, filed 25 Jan 2024.